You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

Article info

Article menu
Download PDFPDF
ABSTRACT: Oral Poster Presentations: Cervical Cancer Tuesday, October 17, 2006
0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

Authors

Citation

Mirza MR, Depont R, Lund B, et al
0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)
International Journal of Gynecologic Cancer 2006;16:620.
Online issue publication 
December 17, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2006 IGCS, International Journal of Gynecological Cancer